Order results by:
Issue | Title | |
Vol 14, No 4 (2022) | Effect of statins on oxidative stress and cognitive function in patients with cerebral atherosclerosis: results of a prospective cohort study | Abstract similar documents |
K. V. Nikulina, O. V. Vorobieva, V. V. Fateeva | ||
"... , but an improvement in oxidative performance was only in group 1. The positive effect of statins on CF was manifested ..." | ||
Vol 14, No 2 (2022) | Association between redox imbalance, pterin metabolism markers, and early extrapyramidal side effects of antipsychotics in schizophrenia: pilot study | Abstract similar documents |
T. V. Zhilyaeva, D. S. Shvachkina, A. S. Piatoikina, E. S. Zhukova, O. V. Kostina, T. G. Shcherbatyuk, G. E. Mazo | ||
"... effects (SE), in particular, with extrapyramidal (EP). Data suggests that oxidative damage to dopaminergic ..." | ||
Vol 11, No 1 (2019) | The mechanisms for activation of a vascular platelet component of hemostasis in the stroke recovery period and the ways of their correction | Abstract similar documents |
E. A. Tyutyumova, E. Yu. Solovyeva, A. N. Karneev, E. D. Dzhutova | ||
"... intercellular interaction processes (ASA, clopidogrel, and statins), and suppress oxidative stress associated ..." | ||
Vol 9, No 2 (2017) | Chronic cerebral ischemia, neuroplasticity, possibilities of therapy | Abstract similar documents |
E. I. Chukanova, A. S. Chukanova | ||
Vol 7, No 2 (2015) | Postoperative encephalopathy: Pathophysiological and morphological bases of its prevention under general anesthesia | Abstract similar documents |
A. M. Ovezov, A. V. Knyazev, M. V. Panteleeva, M. A. Lobov, M. N. Borisova, A. V. Lugovoy | ||
Vol 14, No 4 (2022) | The role of oxidative stress in the development of Alzheimer's disease | Abstract similar documents |
V. N. Nikolenko, N. A. Rizaeva, K. V. Bulygin, V. M. Anokhina, A. A. Bolotskaya | ||
"... Oxidative stress is one of the main mechanisms for the development of Alzheimer's disease (AD ..." | ||
Vol 14, No 4 (2022) | Control of dyslipidemia in the prevention of recurrent ischemic cerebrovascular accidents (expert opinion) | Abstract similar documents |
M. M. Tanashyan, N. A. Shamalov, I. A. Voznyuk, S. N. Yanishevsky, O. I. Vinogradov, D. R. Khasanova, O. V. Tikhomirova, V. A. Parfenov, E. V. Oshchepkova, M. V. Ezhov, V. S. Gurevich, V. V. Arkhipov | ||
"... stroke (IS) and transient ischemic attack (TIA) it is recommended to start or continue statin therapy ..." | ||
Vol 6, No 2S (2014): Special issue "Stroke" | Specific features of free radical processes in comorbid patients with acute stroke and transient ischemic attack | Abstract similar documents |
A.S. Orlova, E.V. Silina, S.A. Rumyantseva, V.A. Stupin, N.I. Menshova, V.A. Orlov, T.G. Sinelnikova, S.B. Bolevich | ||
"... . Plasma FRP was investigated over time from the oxygen and lipid peroxide markers of oxidative stress ..." | ||
Vol 1, No 1 (2009) | USE OF ACTOVEGIN IN NEUROLOGY | Abstract similar documents |
Yu. A. Starchina | ||
"... the mechanisms of hypoxia, ischemia, and oxidative stress. ..." | ||
Vol 4, No 1 (2012) | Current approaches to therapy for chronic forms of cerebrovascular diseases | Abstract similar documents |
Maksim Alekseyevich Domashenko, M Yu Maksimova, T A Popova, M M Tanashyan | ||
"... with atrial fibrillation, in a number of patients with coagulation), antihypertensive drugs, statins. Based ..." | ||
Vol 4, No 4 (2012) | Current approaches to preventing and treating chronic cerebral circulatory disorder | Abstract similar documents |
Marina Yuryevna Maksimova, M A Domashenko, M M Tanashyan | ||
"... hypertension), indirect anticoagulants (for atrial fibrillation), statins. It details the results of clinical ..." | ||
Vol 3, No 2 (2011) | Arterial rigidity and cerebrovascular disorders | Abstract similar documents |
L. A. Geraskina, A. V. Fonyakin, A. R. Magomedova | ||
"... of lifestyle, and the use of antihypertensive and antithrombotic agents and statins. AR whose correction ..." | ||
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Motor function recovery in patients after ischemic stroke | Abstract similar documents |
Yu. A. Starchina | ||
"... drugs and statins) are recommended for use; and a small proportion of patients should undergo surgical ..." | ||
Vol 6, No 2S (2014): Special issue "Stroke" | Arterial hypertension and stroke: cardiac and neurological aspects of secondary prevention | Abstract similar documents |
L.A. Geraskina | ||
"... antiplatelet therapy and statins. The most important part is assigned to the prevention and treatment ..." | ||
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Mechanisms of valproate-induced teratogenesis | Abstract similar documents |
D. V. Dmitrenko, N. A. Shnaider, I. G. Strotskaya, A. S. Kichkaylo, S. N. Zobova | ||
"... -induced teratogenesis. It discusses the mechanisms of fetal valproic acid accumulation, oxidative stress ..." | ||
Vol 8, No 3 (2016) | Diagnosis and treatment of chronic cerebrovascular disease, use of pentoxifylline | Abstract PDF (Eng) similar documents |
V. A. Parfenov | ||
"... of antihypertensivemedications), to reduce blood cholesterol levels (statins), to perform antithrombotic therapy (antiplatelet ..." | ||
Vol 5, No 4 (2013) | Outpatient management after severe stroke with dementia | Abstract similar documents |
Natalia Vyacheslavovna Pizova | ||
"... , use of antithrombotic agents and statins (after prior ischemic stroke), treatment of cognitive ..." | ||
Vol 5, No 2S (2013): Special issue "Stroke" | Management of a post-stroke patient | Abstract similar documents |
Vladimir Anatolyevich Parfenov, S V Verbitskaya | ||
"... procedures (in some patients), antithrombotic agents, and statins (after ischemic stroke). It analyzes ..." | ||
Vol 2, No 2 (2010) | Clinical experience in using cereton in ischemic stroke and dyscirculatory encephalopathy | Abstract similar documents |
L. P. Ponomareva, N. F. Timoshkina, L. N. Sarantseva, A. A. Bulanov | ||
"... , statins, and, in some patients, surgical treatments, plays a dominant role in the treatment of patients ..." | ||
Vol 6, No 1 (2014) | The use of neurocytoprotectors to improve rehabilitation of patients after cerebrovascular accident | Abstract similar documents |
V.V. Kovalchuk | ||
"... , statins) and restoring the lost functions (therapeutic exercise, etc.). Additionally, 125 patients ..." | ||
Vol 15, No 3 (2023) | Patient with non-cardioembolic ischemic stroke or high-risk transient ischemic attack. Part 2. Secondary prophylaxis | Abstract similar documents |
A. A. Kulesh, S. N. Yanishevsky, D. A. Demin, L. I. Syromyatnikova, O. I. Vinogradov | ||
"... with high doses of statins, ezetimibe, PCSK9 inhibitors, or inclisiran to achieve low-density lipoprotein ..." | ||
Vol 13, No 5 (2021) | Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration | Abstract similar documents |
I. V. Sarvilina, O. A. Gromova, A. V. Naumov | ||
"... , and amino acids, impairment of oxidative phosphorylation and glycolysis, hypometabolic state, redox ..." | ||
Vol 15, No 2 (2023) | Prediction of cerebral ischemia during carotid stenting depending on the intensity of the preoperative ultrasound signal from the plaque | Abstract PDF (Eng) similar documents |
M. M. Tanashyan, R. B. Medvedev, P. L. Anufriev, E. G. Gemdzhian, V. L. Shchipakin, A. Yu. Koshcheev, M. V. Krotenkova | ||
"... disability, contraindications for antiplatelet therapy, statins, and MRI examination. All patients underwent ..." | ||
Vol 15, No 2 (2023) | Antioxidant therapy in the complex treatment of patients with ischemic stroke in the acute and recovery period | Abstract similar documents |
Yu. A. Belova, S. V. Kotov | ||
"... mechanisms of IS is oxidative stress as one of the components of brain tissue damage in the acute period ..." | ||
Vol 14, No 6 (2022) | Alzheimer's disease and COVID-19 | Abstract similar documents |
N. N. Koberskaya, F. A. Roshchin | ||
"... inflammation, hyperactivation of the renin-angiotensin system, innate immune activation, oxidative stress ..." | ||
Vol 13, No 3 (2021) | Pathogenesis, evaluation and pathogenetic therapy of diabetic polyneuropathy | Abstract similar documents |
I. A. Strokov, V. V. Oganov | ||
"... ), the most common type of polyneuropathy. Oxidative stress is considered the main reason for the cellular ..." | ||
Vol 13, No 4 (2021) | Neuroprotective therapy in acute ischemic stroke | Abstract similar documents |
A. A. Kulesh | ||
"... are considered. Neuroprotective approaches aimed at suppressing excitotoxicity, oxidative stress ..." | ||
Vol 12, No 1 (2020) | Drug-induced tardive dyskinesia | Abstract similar documents |
T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
"... deficiency, oxidative stress, impaired synaptic plasticity, and neurotoxicity. TD most often occurs after ..." | ||
Vol 16, No 6 (2024) | Vitamins and other nutrients that support nitric oxide homeostasis and counteract the development of endotheliopathy | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, L. A. Mayorova | ||
"... on vascular endothelial function, NO synthase activity and the prevention of oxidative-nitrosative stress ..." | ||
Vol 17, No 1 (2025) | Analysis of the migraine characteristics in the perimenopause | Abstract similar documents |
D. A. Klimentova, G. R. Tabeeva | ||
"... of days with headache per month are significantly higher in perimenopause than in RA (p<0.05). The risk ..." | ||
Профилактика ишемического инсульта | Профилактика ишемического инсульта. Рекомендации по гиполипидемической терапии | Abstract similar documents |
, | ||
"... результатах и перспективах применения статинов в остром периоде ишемического инсульта. Отдельная глава ..." | ||
Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
"... in scores on the HAMD-17 scale was noted in the remission group from the 7th day of agomelatine therapy (p<0.05 ..." | ||
Vol 8, No 1 (2016) | Synergistic neurotrophic effects of piracetam and thiotriazoline | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. V. Pronin, A. Yu. Volkov | ||
"... возраста с ишемической болезнью сердца. Предположительно пирацетам стимулирует окислительно ..." | ||
Vol 7, No 3 (2015) | Cognitive impairments in common and rare somatic diseases | Abstract similar documents |
Natalia Vyacheslavovna Pizova | ||
"... radical-induced cell injury, oxidative stress, excitation toxicity, cell necrosis and/or apoptosis ..." | ||
Vol 15, No 5 (2023) | Possibilities of combined use of peptides in the treatment of post-stroke asthenia | Abstract similar documents |
A. Yu. Emelin, V. Yu. Lobzin | ||
"... of drugs with a complex mechanism of action on hypoxia, oxidative stress, energy deficiency ..." | ||
Vol 12, No 2 (2020) | Quality of life indicators in assessing the results of various surgical treatment methods for cervical myelopathy | Abstract similar documents |
A. A. Chekhonatsky, N. E. Komleva, V. N. Nikolenko, V. A. Chekhonatsky | ||
"... .7±2.1 to 49.6±3.1 arbitrary units (arb. unit) (p<0.05) and in role physical functioning from 39.4±2 ..." | ||
Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
"... ) 29.2–34.1; α<0.05); the disease duration was 4.69 months (CI 3.31–6.08; α<0.05); the EDSS scores ..." | ||
Vol 9, No 1 (2017) | Evaluation of the safety and efficacy of the Russian botulinum toxin-A relatox versus botox in treating arm and hand spasticity after ischemic stroke: A multicenter randomized trial | Abstract similar documents |
S. E. Khatkova, E. V. Kostenko, D. V. Pokhabov, A. V. Gustov, A. N. Kalyagin, N. G. Zhukova | ||
"... muscle tone according to the Ashworth scale (p<0.05), which was recorded at all visits as compared ..." | ||
Vol 13, No 2 (2021) | Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) | Abstract similar documents |
V. A. Kutashov | ||
"... scores (p<0.05), lower MFI (p<0.05), and Spielberger-Hanin test scores (p<0.05) compared to the control ..." | ||
Vol 13, No 6 (2021) | The effect of sleep duration on the risk of diabetes mellitus in an open population of men aged 45–64 years (international epidemiological studies) | Abstract PDF (Eng) similar documents |
V. V. Gafarov, E. A. Gromova, D. O. Panov, L. V. Shcherbakova, A. N. Tripelgorn, S. K. Malyutina, O. D. Rymar, S. V. Mustafina, I. V. Gagulin, A. V. Gafarova | ||
"... , 7-hour sleep prevailed – 39.2%, 6- and 8-hour sleep – 25.3% each (÷2=7.774; df=5; p>0.05). In men ..." | ||
Vol 15, No 5 (2023) | Comprehensive diagnosis of cervical dystonia and the efficacy of long-term (three-year) botulinum therapy | Abstract similar documents |
V. A. Tolmacheva, D. S. Petelin, B. A. Volel | ||
"... there was an increase in the severity of anxiety up to 9.93±4.7 points (in the control group – 4.28±3.5 points; p≤0.05 ..." | ||
Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
"... .001), the ability to memorize 12 words – from 7.5±1.8 to 8.7±2.1 words (p<0.05), categorical associations – from 14 ..." | ||
Vol 14, No 1 (2022) | Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study | Abstract similar documents |
O. V. Vorobyeva, A. A. Pilipovich, V. V. Fateeva | ||
"... with subclinical depression (n=116): CRP – 2.03 mg/l, МСР-1 – 0.66 ng/ml (р<0.05). Correlation analysis showed ..." | ||
Vol 3, No 4 (2011) | Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease | Abstract similar documents |
M. A. Bykanova, A. Yu. Kovalchuk, N. V. Pizova, N. G. Efremenko, A. A. Kostylev | ||
"... than in those with mixed and left IPFIAs (p<0.05). Left-sided PD onset was significantly more common ..." | ||
Vol 14, No 6 (2022) | Features of pathogenesis and risk factors of in-hospital ischemic stroke | Abstract similar documents |
S. V. Kolomentsev, N. V. Tsygan, I. A. Voznyuk, S. N. Yanishevskiy, E. I. Shermatyuk, O. M. Ilyina, I. V. Litvinenko | ||
"... of strokes of another established etiology was 24.8% and was higher than in therapeutic (9.8%; p<0.05 ..." | ||
Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
"... and discussion. After 3 months, only the piribedil group showed a significant neuropsychological improvement (p<0.05 ..." | ||
Vol 7, No 1S (2015): Special issue "Epilepsy" | Specific features of epilepsy in children with brain tumors | Abstract similar documents |
G. V. Kalmykova, A. F. Neretina, Zh. Yu. Chefranova | ||
"... epilepticus in 9% of the patients. Different types of generalized seizures were more common (53%; p≥0.05 ..." | ||
Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Analysis of migraine characteristics in postmenopausal women | Abstract similar documents |
D. A. Klimentova, O. V. Kosivtsova, A. V. Sergeev, G. R. Tabeeva | ||
"... in patients in the PM than in patients in the RP [p<0.05; relative risk (RR) 1.77]. The risk of necessity ..." | ||
Vol 16, No 3 (2024) | Impact of COVID-19 on mild vascular cognitive impairment in patients with atrial fibrillation: results of a three-year observational study | Abstract similar documents |
O. V. Vorob'eva, N. N. Shindryaeva, V. V. Fateeva | ||
"... IIIarterialhyper-tension (46.2% vs. 17.9% in group 2; p<0.05), had a history of ischemic stroke (38.5% vs. 5 ..." | ||
Vol 15, No 3 (2023) | Prediction of restoration of swallowing function in patients with ischemic stroke and neurogenic dysphagia | Abstract similar documents |
A. A. Borzdyko, V. I. Ershov, N. V. Gumalatova, T. Yu. Lozinskaya, E. D. Lutsai | ||
"... in severity (p<0.05). In the cardioembolic subtype of IS, the probability of switching patients to self ..." | ||
Vol 14, No 2 (2022) | Cognitive functions and professional status in the open population of Russia/Siberia among adults aged 25–44 years | Abstract PDF (Eng) similar documents |
A. V. Sukhanov, M. I. Voevoda, E. A. Gromova, D. V. Denisova, V. V. Gafarov | ||
"... words it reached 0.735 words, and in delayed recall – 1.096 words (p<0.05). Attention assessment using ..." | ||
Vol 15, No 1 (2023) | Association of sleep disorders with various polymorphic variants of the 5-HTTLPR SNP rs25531 A>G gene in people aged 25–44 | Abstract similar documents |
V. V. Gafarov, E. A. Gromova, I. V. Gagulin, D. O. Panov, V. N. Maksimov, M. A. Gubina, A. V. Gafarova | ||
"... =11.397; df=4; p<0.05). In 19.6% of men and 21.5% of women, sleep duration was 6 hours per day, 5 ..." | ||
Vol 11, No 3 (2019) | Secondary hypokalemic myoplegias | Abstract similar documents |
T. G. Sakovets, E. I. Bogdanov | ||
"... etiology, there were shorter (5.8±4-day) muscle weakness episodes (p<0.05). The SHM duration was recorded ..." | ||
Vol 15, No 3 (2023) | Association of the circadian rhythm gene ARNTL/BMAL1 with personal anxiety among people aged 25–64 (WHO international program “MONICA-psychosocial (MOPSY)”) | Abstract PDF (Eng) similar documents |
V. V. Gafarov, E. A. Gromova, I. V. Gagulin, D. O. Panov, V. N. Maksimov, А. V. Gafarova | ||
"... genotypes of the ARNTL gene was 2 times higher (p<0.05) in the general population and 2.4 times (p<0.05 ..." | ||
Vol 13, No 6 (2021) | Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease | Abstract similar documents |
E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova | ||
"... those who did not take adamantanes (p<0.05). At the same time, there were no significant differences ..." | ||
Vol 14, No 3 (2022) | The efficacy of ipidacrine in patients with diabetic polyneuropathy | Abstract similar documents |
P. R. Kamchatnov, E. R. Barantsevich, A. V. Chugunov, A. A. Kabanov, B. A. Abusueva | ||
"... group, the total scores on the NSS scale decreased by 37% (p<0.05) by the 60th day of treatment ..." | ||
Vol 12, No 3 (2020) | The efficiency and tolerability of lacosamide therapy in adolescents and adults with new-onset focal epilepsy in terms of the epileptiform activity index | Abstract PDF (Eng) similar documents |
V. A. Karlov, P. N. Vlasov, A. B. Kozhokaru, A. S. Samoilov, A. S. Orlova | ||
"... 2.92 [0; 6.7] to 1.95 [0; 3.07] (p<0.05). LCM demonstrated a high efficacy and a good tolerance ..." | ||
Vol 13, No 2 (2021) | Depression, anxiety and motivation in arterial hypertension | Abstract similar documents |
S. K. Mezhmidinova, V. V. Zakharov, N. V. Vakhnina | ||
"... pressure level (p<0.05) and AH duration (p<0,05) were significantly associated with the severity of each ..." | ||
Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Carpal tunnel syndrome: issues of diagnosis and treatment | Abstract similar documents |
A. S. Gilveg, V. A. Parfenov, G. Yu. Evzikov | ||
"... .24±0.41 at 1 and 12 months, respectively (p<0.05), the mean functional state score dropped from 2.92±0 ..." | ||
Vol 11, No 3 (2019) | Posthypoxic encephalopathy in patients undergoing coronary artery bypass surgery: clinical, neuropsychological, and neuroimaging aspects | Abstract similar documents |
O. A. Portik, Yu. N. Tsarevskaya, A. Yu. Efimtsev, T. M. Alekseeva, G. E. Trufanov | ||
"... . Posthypoxic encephalopathy was diagnosed in 10 and 67% of patients in Group 1 and 2, respectively (p=0.05 ..." | ||
Vol 16, No 6 (2024) | Efficacy of cognitive behavioral therapy in chronic migraine and medication overuse headache: a prospective randomized trial | Abstract similar documents |
V. A. Golovacheva, A. A. Golovacheva | ||
"... , a statistically significant improvement (p<0.05) was observed in group 1: reduction in headache frequency ..." | ||
Vol 13, No 5 (2021) | Awareness of cardiovascular diseases risk factors, attitude towards their health and sleep disorders among the 25–64 years old population in Russia/Siberia (WHO International «MONICA-psychosocial» program) | Abstract PDF (Eng) similar documents |
V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelhorn, A. V. Gafarova | ||
"... – 3.6%, χ2 =24.142, df=8, p<0.01 and women – 3.7%, χ2 =15.538, df=8, p<0.05) only some heart diseases ..." | ||
Vol 14, No 1 (2022) | Comparative evaluation of psychopharmacotherapy of atypical depression in bipolar and recurrent affective disorder, psychogenic depression | Abstract PDF (Eng) similar documents |
M. S. Verbitskaya, N. A. Tyuvina, Yu. G. Tyulpin, G. L. Krenkel | ||
"... .8%) and effective AD in all groups. Also, escitalopram, vortioxetine, and venlafaxine (p˂0.05) showed high efficacy ..." | ||
Vol 13, No 5 (2021) | Insomnia in chronic non-specific low back pain | Abstract similar documents |
I. A. Lamkova, V. A. Parfenov | ||
"... (p<0.05). Sleep quality between 7th and 90th days significantly improved only in the extended therapy ..." | ||
Vol 10, No 3 (2018) | The level of interleukin-6 in acute ischemic stroke: effect on the rate of recovery in patients and on the severity of neurological defect | Abstract similar documents |
S. P. Sergeeva, А. А. Savin, I. D. Breslavich, P. F. Litvitsky, V. V. Arkhipov | ||
"... : hypercholesterolemia of days 1, 7 (p<0.01) and 21 (p<0.05), hypertension in day 1 (p<0.05), diabetes mellitus on days 1 ..." | ||
Vol 16, No 4 (2024) | Kinesiotherapy in painful diabetic polyneuropathy | Abstract similar documents |
E. V. Mandra, V. A. Parfenov, L. T. Akhmedzhanova, E. S. Shulakova, V. V. Fadeev, M. V. Amosova | ||
"... groups did not differ (p ≥ 0.05) in parameters such as pain intensity according to VAS (6.65 ± 1.93 and 6 ..." | ||
Vol 8, No 3 (2016) | Cardiointervalography in patients with multiple sclerosis | Abstract similar documents |
A. R. Rakhmatullin, K. Z. Bakhtiyarova, R. V. Magzhanov | ||
"... (Cresp, C30:15, and CVals) in MS patients (p<0.05). The isometric contraction test showed a statistically ..." | ||
Vol 4, No 2 (2012) | Secondary prevention of ischemic stroke: from recommendations to real clinical practice | Abstract similar documents |
V A Shandalin, A V Fonyakin, L A Geraskina | ||
"... with antithrombotic agents, indirect anticoagulants in particular (p < 0.05). ..." | ||
Vol 4, No 2 (2012) | Influence of a complex of muscle-strengthening exercises on quality of life in lumbosacral pain | Abstract similar documents |
I A Zaitseva | ||
"... ascertained to be diminished statistically significantly (p <0.05). Conclusion. The developed procedure ..." | ||
Vol 14, No 5 (2022) | The relationship between dissociative experiences and childhood trauma in nursing and midwifery students | Abstract PDF (Eng) similar documents |
F. F. Arabpour, Sh. Amini, R. Bidaki, R. Ashtari, F. Sepehri, A. Moghadam Ahmadi, H. Bakhshi, B. Bozorg | ||
"... and dissociative experiences score (P<0.05). Conclusion. The prevalence of dissociative experiences among ..." | ||
1 - 70 of 159 Items | 1 2 3 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)